A Study of LY2140023 in Healthy Participants

NCT01609218 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
27
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Denovo Biopharma LLC